Pharmacielo (TSE:PCLO) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
PharmaCielo announces a landmark supply deal with Ease Labs, enabling the distribution of their pharma-grade CBD as part of São Paulo’s public health program, targeting patients with specific syndromes. The partnership signifies a major step for PharmaCielo into the Brazilian market, leveraging the growing demand for cannabinoid-based treatments. This initiative also aligns with previous legal decisions mandating government support for CBD treatments in Brazil.
For further insights into TSE:PCLO stock, check out TipRanks’ Stock Analysis page.
